Third biannual report of the Cochrane Haematological Malignancies Group

J Natl Cancer Inst. 2005 Aug 17;97(16):E2. doi: 10.1093/jnci/dji258.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Marrow Transplantation*
  • Burkitt Lymphoma / therapy
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Disease-Free Survival
  • Drug Administration Schedule
  • Hematologic Neoplasms / drug therapy
  • Hematologic Neoplasms / surgery
  • Hematologic Neoplasms / therapy*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, Myeloid, Acute / therapy
  • Lymphoma, Follicular / therapy
  • Lymphoma, Large B-Cell, Diffuse / therapy
  • Lymphoma, Mantle-Cell / therapy
  • Multicenter Studies as Topic
  • Multiple Myeloma / therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Survival Analysis
  • Treatment Outcome